Citigroup Initiates Coverage On 10x Genomics with Buy Rating, Announces $100 Price Target

Citigroup analyst Patrick Donnelly initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating and a $100 price target.

Benzinga · 01/07/2020 11:59

Citigroup analyst Patrick Donnelly initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating and a $100 price target.